Literature DB >> 28527688

Clinical development of a VAR2CSA-based placental malaria vaccine PAMVAC: Quantifying vaccine antigen-specific memory B & T cell activity in Beninese primigravidae.

Komi Gbédandé1, Nadine Fievet2, Firmine Viwami3, Sem Ezinmegnon4, Saadou Issifou5, Jean-Philippe Chippaux6, Yannelle Dossou7, Kabirou Moutairou8, Achille Massougbodji9, Nicaise Ndam10, Willem Adriaan de Jongh11, T Max M Søgaard12, Ali Salanti13, Morten A Nielsen14, Meral Esen15, Benjamin Mordmüller16, Philippe Deloron17, Adrian J F Luty18.   

Abstract

BACKGROUND: The antigen VAR2CSA plays a pivotal role in the pathophysiology of pregnancy-associated malaria (PAM) caused by Plasmodium falciparum. A VAR2CSA-based vaccine candidate, PAMVAC, is under development by an EU-funded multi-country consortium (PlacMalVac project). As part of PAMVAC's clinical development, we quantified naturally acquired vaccine antigen-specific memory B and T cell responses in Beninese primigravidae recruited at the beginning of pregnancy and followed up to delivery and beyond.
METHODS: Clinical and parasitological histories were compiled from monthly clinic visits. On 4 occasions (first and fifth month of pregnancy, delivery, 6months post-delivery) peripheral blood mononuclear cells were isolated for in vitro assays. PAMVAC-specific memory B cells as well as those specific for a PAM unrelated P. falciparum antigen (PfEMP1-CIDR1a) and for tetanus toxoid were quantified by ELISpot. Memory T cell responses were assessed by quantifying cytokines (IL-5, IL-6, IL-10, IL-13, IFN-γ, TNF-α) in supernatants of cells stimulated in vitro either with PAMVAC, or mitogen (PHA).
RESULTS: Both tetanus toxoid- and PAMVAC-specific memory B cell frequencies increased to reach peak levels in the 5th month and at delivery, respectively and persisted post-delivery. The frequency of CIDR1a-specific memory B cells was stable during pregnancy, but declined post-delivery. The cumulated prevalence of infection with P. falciparum during pregnancy was 61% by microscopy. In women with a history of such infections, a significantly higher frequency of PAMVAC-specific memory B cells was observed at delivery. PAMVAC-specific pro-inflammatory (IFN-γ, TNF) responses tended to be higher at delivery in those with a history of infection. Mitogen-induced IL-5/IL-13 responses were significantly enhanced in the same women.
CONCLUSIONS: PAMVAC-specific memory B cells are induced during first pregnancies and are maintained post-delivery. Women with a T helper cell profile biased towards production of Th2-type cytokines have a greater risk of infection with P. falciparum.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cytokines; Malaria; Pregnancy; T & B cells; VAR2CSA; Vaccine

Mesh:

Substances:

Year:  2017        PMID: 28527688     DOI: 10.1016/j.vaccine.2017.05.027

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  9 in total

1.  Submicroscopic Plasmodium infection during pregnancy is associated with reduced antibody levels to tetanus toxoid.

Authors:  C Álvarez-Larrotta; O M Agudelo; Y Duque; K Gavina; S K Yanow; A Maestre; J Carmona-Fonseca; E Arango
Journal:  Clin Exp Immunol       Date:  2018-10-19       Impact factor: 4.330

2.  Production of PfEMP1-Specific Human Monoclonal Antibodies from Naturally Immune Individuals.

Authors:  Melanie R Walker; Lea Barfod
Journal:  Methods Mol Biol       Date:  2022

3.  Cohort profile: effect of malaria in early pregnancy on fetal growth in Benin (RECIPAL preconceptional cohort).

Authors:  Manfred Accrombessi; Emmanuel Yovo; Gilles Cottrell; Gino Agbota; Agnès Gartner; Yves Martin-Prevel; Nadia Fanou-Fogny; Diane Djossinou; Jennifer Zeitlin; Nicaise Tuikue-Ndam; Florence Bodeau-Livinec; Sandrine Houzé; Nicola Jackson; Paul Ayemonna; Achille Massougbodji; Michel Cot; Nadine Fievet; Valérie Briand
Journal:  BMJ Open       Date:  2018-01-08       Impact factor: 2.692

4.  IgG Responses to the Plasmodium falciparum Antigen VAR2CSA in Colombia Are Restricted to Pregnancy and Are Not Induced by Exposure to Plasmodium vivax.

Authors:  Mary Lopez-Perez; Mads Delbo Larsen; Rafael Bayarri-Olmos; Paulina Ampomah; Liz Stevenson; Myriam Arévalo-Herrera; Sócrates Herrera; Lars Hviid
Journal:  Infect Immun       Date:  2018-07-23       Impact factor: 3.441

5.  First-in-human, Randomized, Double-blind Clinical Trial of Differentially Adjuvanted PAMVAC, A Vaccine Candidate to Prevent Pregnancy-associated Malaria.

Authors:  Benjamin Mordmüller; Mihály Sulyok; Diane Egger-Adam; Mafalda Resende; Willem A de Jongh; Mette H Jensen; Helle Holm Smedegaard; Sisse B Ditlev; Max Soegaard; Lars Poulsen; Charlotte Dyring; Carlos Lamsfus Calle; Annette Knoblich; Javier Ibáñez; Meral Esen; Philippe Deloron; Nicaise Ndam; Saadou Issifou; Sophie Houard; Randall F Howard; Steven G Reed; Odile Leroy; Adrian J F Luty; Thor G Theander; Peter G Kremsner; Ali Salanti; Morten A Nielsen
Journal:  Clin Infect Dis       Date:  2019-10-15       Impact factor: 9.079

Review 6.  Plasmodium falciparum Blood Stage Antimalarial Vaccines: An Analysis of Ongoing Clinical Trials and New Perspectives Related to Synthetic Vaccines.

Authors:  David Ricardo Salamanca; Marcela Gómez; Anny Camargo; Laura Cuy-Chaparro; Jessica Molina-Franky; César Reyes; Manuel Alfonso Patarroyo; Manuel Elkin Patarroyo
Journal:  Front Microbiol       Date:  2019-12-03       Impact factor: 5.640

7.  A brief review on features of falciparum malaria during pregnancy.

Authors:  Alexandre Manirakiza; Eugène Serdouma; Richard Norbert Ngbalé; Sandrine Moussa; Samuel Gondjé; Rock Mbetid Degana; Gislain Géraud Banthas Bata; Jean Methode Moyen; Jean Delmont; Gérard Grésenguet; Abdoulaye Sepou
Journal:  J Public Health Afr       Date:  2017-12-31

8.  Dynamics of Submicroscopic Plasmodium falciparum Infections Throughout Pregnancy: A Preconception Cohort Study in Benin.

Authors:  Cornélia P A Hounkonnou; Valérie Briand; Nadine Fievet; Manfred Accrombessi; Emmanuel Yovo; Atikatou Mama; Darius Sossou; Bertin Vianou; Achille Massougbodji; Nicaise Tuikue Ndam; Michel Cot; Gilles Cottrell
Journal:  Clin Infect Dis       Date:  2020-06-24       Impact factor: 9.079

Review 9.  [Development of malaria vaccines-state of the art].

Authors:  Wolfram Gottfried Metzger; Zita Sulyok; Antje Theurer; Carsten Köhler
Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz       Date:  2020-01       Impact factor: 1.513

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.